These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3735922)

  • 1. [Role of prolactin in disorders of water and salt metabolism in patients with hypertension].
    Ziabreva EV; Bol'shakova TD; Gitel' EP; Lukovnikova LP; Podzolkov VI
    Kardiologiia; 1986 May; 26(5):64-7. PubMed ID: 3735922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect evidence to suggest that prolactin induces salt retention in cirrhosis.
    Soupart A; Buisson L; Prospert F; Decaux G
    J Hepatol; 1994 Sep; 21(3):347-52. PubMed ID: 7836703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased water excretion in hyperprolactinemic rats.
    Adler RA; Herzberg VL; Brinck-Johnsen T; Sokol HW
    Endocrinology; 1986 Apr; 118(4):1519-24. PubMed ID: 3004920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
    Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
    Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
    Arafah BM; Gordon NH; Salazar R; Douglas JG
    J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does elevated morning prolactin concentration in children always mean the diagnosis of hyperprolactinemia?
    Stawerska R; Smyczyńska J; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Jul; 123(7):405-10. PubMed ID: 26069077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
    Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carbohydrate metabolism in normo- and hyperprolactinemic sterile patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
    Alexander H; Ulrich FE; Herter U
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6242682
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
    Fukunaga T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin enhancement of its own uptake at the choroid plexus.
    Mangurian LP; Walsh RJ; Posner BI
    Endocrinology; 1992 Aug; 131(2):698-702. PubMed ID: 1639017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute administration of bromocriptine abolishes the hyperprolactinemic response induced by submaximal exercise in man.
    Boisvert P; Brisson GR; Péronnet F; Gareau R
    Can J Physiol Pharmacol; 1992 Oct; 70(10):1379-83. PubMed ID: 1490255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalciuria in hyperprolactinemic rats: effects of benzthiazide.
    Adler RA; Costanzo LS; Stauffer ME
    Metabolism; 1986 Jul; 35(7):668-72. PubMed ID: 3724459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary electrolyte excretion and plasma corticoid level at the furosemide administration test in low renin hypertension].
    Nigawara K; Kogawa T; Inazumi S; Yagihashi Y; Suzuki T; Funyu T; Kawamata A; Tulachan Y; Kudo T; Terayama Y
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):385-98. PubMed ID: 6750183
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of hydergine in hyperprolactinemia.
    Tamura T; Satoh T; Minakami H; Tamada T
    J Clin Endocrinol Metab; 1989 Aug; 69(2):470-4. PubMed ID: 2753986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of dopaminergic system function in menopausal females with arterial hypertension].
    Ustinova SE; Iarnykh EV; Masenko VP; Arabidze GG
    Ter Arkh; 2000; 72(1):35-40. PubMed ID: 10687204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin circadian rhythm in women with idiopathic hyperprolactinemia.
    Karasek M; Stawerska R; Hilczer M; Zylinska K; Lewinski A
    Neuro Endocrinol Lett; 2004 Dec; 25(6):411-4. PubMed ID: 15665801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.